InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,285.94
(
0.34%
)
US TECH 100
18,196.82
(
0.28%
)
Dow Jones
39,138.07
(
0.19%
)
Brent Oil
81.56
(
0.30%
)
Bitcoin
67,263.49
(
-0.97%
)
Post# of 13742
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

~MulaGreen~

Send PM Follow Ignore
Followers 1171
Posts 34538
Boards Moderated 0
Alias Born 03/26/2007

~MulaGreen~

Re: powerbattles post# 4050

Wednesday, 05/19/2021 11:53:22 AM

Wednesday, May 19, 2021 11:53:22 AM

Post# of 13742
The FDA IND of Escozine® upon Approval,essentially allowing the drug to be distributed in the US.

After such designation, the Company will pursue other clinical applications of Escozine®, including as a potential cancer therapeutic where the Company has already released positive clinical results.

https://finance.yahoo.com/news/medolife-rx-submits-final-data-123000200.html

Too Bad PB that a few here have a problem in comprehending or understanding
this recent news...or prolly not reading it entirely befor spouting something they don't understand.

So many links for DD were and are provided here. but these miscreants are getting into the Board Discussions with a Pebble mind...lol
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up